Résumé
In a first aspect, the present invention relates to methods and pharmaceutical compositions for modulating tear film composition in a subject in need thereof, comprising administering into the lacrimal gland of said subject a vector comprising a nucleic acid encoding a protein of interest. The methods of the invention are particularly suitable to treat corneal defects in subject in need thereof.